Real-time · AI · Cross-signal
Discover the power of real-time signals plus AI
Every contract, funding round, exec hire, and M&A move on IO Biotech — with verified, ICP-scored contact reveals (email + mobile) on demand.
Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.
IO Biotech secures up to €57.5 million in debt financing from the European Investment Bank
Dec 20, 2024•over 1 year ago
Contract Type
agreement
Description
IO Biotech, a clinical-stage biopharmaceutical company, has secured a loan facility of up to €57.5 million from the European Investment Bank (EIB) to fund the continued development and pre-commercialization of IO102-IO103 and other therapeutic cancer vaccine candidates.
Related People
Suggested for you
Sign in to view contact details
Agreement Insights
Based on industry dataContract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months